Search the Newsreel

Can Organigram (TSX:OGI) Cannabis Stocks Capture Greater Share?

Organigram Holdings (TSX:OGI) is strategically positioning itself in the competitive Canadian cannabis market through brand diversification across premium, mainstream, and value segments, and product innovation to include vapes and edibles. The company also uses strategic consolidation to achieve greater scale and operational efficiency, aiming …

Citigroup affirms Excelerate Energy's Outperform rating after strong Q2 with raised EBITDA forecast.

Citigroup has reaffirmed its Outperform rating on Excelerate Energy following strong Q2 2026 results, which saw net income of $50.1 million and adjusted EBITDA of $120.1 million, surpassing estimates. The company raised its full-year adjusted EBITDA forecast to $490-$515 million, driven by new projects …

Citigroup Inc. stock outperforms competitors on strong trading day

Citigroup Inc. stock (C) rose by 1.33% to $137.58 on Wednesday, outperforming the mixed market, with the S&P 500 Index gaining 0.26% and the Dow Jones Industrial Average falling 0.04%. This marks the fourth consecutive day of gains for the stock.

Is Organigram (TSX:OGI) Entering A Stronger Growth Phase?

Is Citigroup (C) Undervalued After Its Latest Bond Offerings?

Citigroup (C) has been active in the bond market with new bond offerings. Despite a recent slight dip in share price, its 1-year total shareholder return is strong, leading to a "Most Popular Narrative" that values the stock at $154.00, suggesting it is undervalued. …

Organigram Global Inc. Q3 2026 Earnings Call Summary

Organigram Global Q3 Earnings Call Highlights

Organigram Global reported record Q3 fiscal 2026 revenue of C$105.8 million and adjusted EBITDA of C$13.4 million, driven by the acquisition of Germany-based Sanity Group and improved performance in Canadian cannabis categories. Sanity Group contributed approximately C$40 million to revenue, significantly increasing Organigram's international …

Wedge Capital Management L L P NC Lowers Stake in Citigroup Inc. $C

Wedge Capital Management L L P NC reduced its stake in Citigroup Inc. by 6.7% in the second quarter, selling 18,194 shares and now holding 254,560 shares valued at $35.6 million. Despite this reduction, Citigroup reported strong quarterly results with higher-than-expected EPS and revenue, …

Northside Capital Management LLC Reduces Holdings in Citigroup Inc. $C

Northside Capital Management LLC reduced its stake in Citigroup Inc. by 28.4% in the second quarter, selling 34,091 shares and retaining 85,841 shares valued at approximately $12.0 million. Despite this, institutional investors own a significant 71.72% of Citigroup. The company recently reported strong quarterly …

Citigroup Adjusts Price Target on Howmet Aerospace to $329 From $311, Keeps Buy Rating

Citigroup has raised its price target for Howmet Aerospace (HWM) to $329 from $311, while maintaining a Buy rating on the stock. This adjustment reflects an updated outlook from the financial firm on the aerospace company's valuation. The report was published by MT Newswires …

Organigram Global Stock Builds Bullish Pressure as Record Quarter, European Expansion and Sector Optimism Lift TSX:OGI

OGI Stock Builds Momentum As Sanity Group Delivers In Germany

Organigram Global Inc. (OGI) stock is trending up due to investor optimism driven by its newly acquired Sanity Group in Germany, which is meeting revenue expectations and holds approximately 10% market share with minimal exposure to adverse reimbursement changes. The company's core Canadian business …

Citigroup Inc. Trims Wolfspeed Inc (WOLF) Stake by 78% in June 2

Citigroup Inc. significantly reduced its stake in Wolfspeed Inc (WOLF) by 78.01% on June 30, 2026, selling over 2.5 million shares at $48.25 each. This move, which leaves Citigroup with a 1.40% ownership stake, reflects a reassessment of Wolfspeed's prospects given its weak financial …

Health Catalyst (NASDAQ:HCAT) Price Target Cut to $2.00 by Analysts at Citigroup

Citigroup has reduced its price target for Health Catalyst (NASDAQ:HCAT) from $2.50 to $2.00, while maintaining a "neutral" rating, indicating a potential 12% upside from its previous close. Despite beating quarterly EPS and revenue estimates, the company continues to report substantial losses, and analysts …

IPG Photonics (NASDAQ:IPGP) Given New $137.00 Price Target at Citigroup

Citigroup has lowered its price target for IPG Photonics (NASDAQ:IPGP) from $150.00 to $137.00 but maintained a "buy" rating, indicating a potential upside of approximately 59% from its current share price. The company recently reported strong quarterly earnings, beating analyst expectations with $0.58 EPS …

Citigroup Has Lowered Expectations for Lumen Technologies (NYSE:LUMN) Stock Price

Citigroup has lowered its price target for Lumen Technologies (NYSE:LUMN) from $10.00 to $8.25, while maintaining a neutral rating, indicating a potential upside of 29.4%. Other analysts have also adjusted their targets, with a consensus "Reduce" rating and an average price target of $7.86. …

Oceaneering International (NYSE:OII) Price Target Raised to $52.00 at Citigroup

Citigroup has increased its price target for Oceaneering International (NYSE:OII) to $52.00 from $40.00, maintaining a "neutral" rating on the stock. This new target implies a potential upside of 2.54% from the previous closing price. Despite the upgrade from Citigroup and others, the company …

P Upgraded by Citigroup -- Price Target Raised to $118

Citigroup has upgraded Everpure Inc (P) to a 'Buy' rating from 'Neutral', raising the price target to $118.00, indicating a potential upside of 31.11%. Despite this positive analyst outlook, GuruFocus assesses P as 45.6% overvalued with a current price of $107.30 against a GF …

Citigroup Lowers Matador Resources (NYSE:MTDR) Price Target to $60.00

Citigroup has reduced its price target for Matador Resources (NYSE:MTDR) from $68.00 to $60.00, while maintaining a "buy" rating, indicating a potential 14.18% upside. Despite this adjustment, analyst sentiment remains a "Moderate Buy" with a consensus price target of $65.29. The company recently reported …

Did Citi’s New Infor Nexus–Powered Trade Platform Quietly Reframe Its Digital Strategy Narrative (C)?

Citigroup Inc. recently launched Citi Consolidate™, an Infor Nexus–powered platform for invoice processing and supply chain finance, now available in the US and Canada. This new digital trade solution integrates automated invoice workflows, cash-flow visibility, and supplier financing, reinforcing Citi's digital trade finance strategy. …

Duolingo adds former Citigroup CFO to board amid monetization shift

Duolingo has appointed Sallie Krawcheck, former Citigroup CFO and Merrill Lynch wealth management head, to its board of directors. This appointment comes as the company is exploring changes to its paid subscription tiers, signaling a strategic shift towards monetization.

Is SGI Stock Worth Buying Amid Growth Gains and Execution Risks?

Somnigroup International (SGI) faces a mixed operating environment with growth opportunities from acquisitions and cash generation, but also challenges from weak bedding demand, margin pressures, and execution risks. While the company benefits from its vertically integrated platform and synergies from the Mattress Firm acquisition, …

OrganiGram Holdings Inc. (OGI) News, Articles, Events & Latest Updates

This article provides recent news and updates on OrganiGram Holdings Inc. (OGI), including its Q3 2026 earnings report where it beat revenue estimates despite a loss. It also covers other health care stocks moving in the pre-market session and announcements regarding Organigram's business updates …

Cannabis Stock Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI) Makes TSX Top Gainer List on Third Quarter Results

Organigram Global (NASDAQ:OGI) Announces Earnings Results, Misses Estimates By $0.04 EPS

OrganiGram (OGI) Reports Q3 Loss, Beats Revenue Estimates

424B2

This preliminary pricing supplement from Citigroup Global Markets Holdings Inc. describes autocallable contingent coupon equity-linked securities tied to the performance of the Nasdaq-100 Index®, Russell 2000® Index, and S&P 500® Index, maturing August 3, 2029. These unsecured debt securities offer potential periodic contingent coupon …

Organigram Global Inc. Q3 Results: Net revenue rises 49% YoY

Organigram Global Inc. reported record Q3 FY26 results, with net revenue increasing by 49% year-over-year to $105.8 million and adjusted EBITDA jumping by 136% to $13.4 million. This significant growth was primarily driven by the acquisition of Sanity Group, which contributed €25 million in …

Earnings call transcript: OrganiGram posts record Q3 2026 revenue as stock rises

OrganiGram Global reported record fiscal Q3 2026 net revenue of CAD 105.8 million and adjusted EBITDA of CAD 13.4 million, driven largely by the consolidation of Sanity Group. The acquisition helped increase international revenue to 35% of total revenue. Despite the strong performance and …

OrganiGram: Fiscal Q3 Earnings Snapshot

MOBILITY GLOBAL INC : CITIGROUP INITIATES COVERAGE WITH NEUTRAL RATING; TARGET PRICE $23

Citigroup has initiated coverage on MOBILITY GLOBAL INC (MBGL.N) with a Neutral rating. The financial institution has set a target price of $23 for the company's stock. This coverage initiation provides investors with an analyst's perspective on MOBILITY GLOBAL INC's market position.

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

This article lists 12 healthcare stocks experiencing significant movement in pre-market trading on Tuesday. It details the percentage change, stock price, and market capitalization for each company, noting recent earnings reports for some. The list includes both gainers like Mereo BioPharma Group and Organigram …

Citigroup, Inc. Announces Appointment of Jean-Baptiste Charlet as Country Officer Banking Head, France

Citigroup Inc. has appointed Jean-Baptiste Charlet, formerly of Morgan Stanley, as its new Country Officer Banking Head for France. This strategic hire is expected to bolster Citi's operations in the French market. The announcement was made on August 11, 2026.

Organigram Global Raises FY26 Revenue Guidance Above Estimates

Organigram Global has raised its revenue guidance for fiscal year 2026, now expecting to exceed $255.197 million, which is above the prior market estimate of $241.360 million. This upward revision reflects strong operational performance and positive market sentiment within the cannabis sector, indicating robust …

Organigram Global (OGI) posts 49% revenue growth and big Q3 revaluation gain

Organigram Global Inc. (OGI) reported strong Q3 Fiscal 2026 results, with net revenue increasing 49% to $105.8 million, largely driven by the acquisition of Germany-based Sanity Group and higher Canadian recreational sales. The company posted a net income of $105.5 million, primarily due to …

Earnings Flash (OGI) Organigram Global Inc. Reports Q3 Revenue C$105.8M, vs. FactSet Est of C$96.9M